Safinamide in Clinical Practice: A Spanish Multicenter Cohort Study

Safinamide in Clinical Practice: A Spanish Multicenter Cohort Study

<b>Background:</b> Safinamide is an approved drug for the treatment of motor fluctuations of Parkinson&#8217;s Disease (PD) patients with a potential benefit on non-motor symptoms (NMS). <b>Methods:</b> A retrospective multicenter cohort study was conducted, in which the...

Full description

Bibliographic Details
Main Authors: Gloria Martí-Andrés, Rayco Jiménez-Bolaños, José Matias Arbelo-González, Javier Pagonabarraga, Carmen Duran-Herrera, Rafael Valenti-Azcarate, Mª Rosario Luquin
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Brain Sciences
Subjects:
parkinson’s disease
safinamide
adverse drug event
dyskinesia
drug-induced
motor complications
Online Access:https://www.mdpi.com/2076-3425/9/10/272

Internet

https://www.mdpi.com/2076-3425/9/10/272

Similar Items